Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Larney

Showing results (81-90 of 187) with videos related to

Pageof 19
Sort By:
MDM Policy & Practice|October 16, 2023
Modeling as Visioning: Exploring the Impact of Criminal Justice Reform on Health of Populations with Substance Use DisordersNatasha K Martin, Leo Beletsky, Benjamin P Linas, et al.
Drug and Alcohol Dependence|February 7, 2018
A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-releaseLauren Brinkley-Rubinstein, Michelle McKenzie, Alexandria Macmadu, et al.
British Journal of Clinical Pharmacology|June 5, 2016
Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiatedNatasa Gisev, Sallie-Anne Pearson, Bianca Blanch, et al.
Drug and Alcohol Dependence|December 28, 2020
Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001-2018: Implications for treatment systems and potential impact on client outcomesNicola R Jones, Suzanne Nielsen, Michael Farrell, et al.
Pain Medicine (Malden, Mass.)|September 20, 2020
All-Cause and Overdose Mortality Risk Among People Prescribed Opioids: A Systematic Review and Meta-analysisSarah Larney, Amy Peacock, Lucy T Tran, et al.
Drug and Alcohol Dependence|March 10, 2018
Erratum to: A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release [Drug and Alcohol Dependence 184 (2018) 57-63]Lauren Brinkley-Rubinstein, Michelle McKenzie, Alexandria Macmadu, et al.
Drug and Alcohol Dependence|May 6, 2022
The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: Findings from the OATS retrospective linkage studyNicola R Jones, Matthew Hickman, Suzanne Nielsen, et al.
Drug and Alcohol Dependence|October 30, 2020
Risk of discharge against medical advice among hospital inpatients with a history of opioid agonist therapy in New South Wales, Australia: A cohort study and nested crossover-cohort analysisDan Lewer, Nicola R Jones, Matthew Hickman, et al.
The International Journal on Drug Policy|June 3, 2017
A mapping review of take-home naloxone for people released from correctional settingsMeredith Horton, Rebecca McDonald, Traci C Green, et al.
The International Journal on Drug Policy|August 10, 2017
Hepatitis C testing in general practice settings: A cross-sectional study of people who inject drugs in AustraliaKerryn Butler, Carolyn Day, Rachel Sutherland, et al.
Pageof 19

Showing results (81-90 of 187) with videos related to

Sort By:
Pageof 19
MDM Policy & Practice|October 16, 2023
Modeling as Visioning: Exploring the Impact of Criminal Justice Reform on Health of Populations with Substance Use DisordersNatasha K Martin, Leo Beletsky, Benjamin P Linas, et al.
Drug and Alcohol Dependence|February 7, 2018
A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-releaseLauren Brinkley-Rubinstein, Michelle McKenzie, Alexandria Macmadu, et al.
British Journal of Clinical Pharmacology|June 5, 2016
Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiatedNatasa Gisev, Sallie-Anne Pearson, Bianca Blanch, et al.
Drug and Alcohol Dependence|December 28, 2020
Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001-2018: Implications for treatment systems and potential impact on client outcomesNicola R Jones, Suzanne Nielsen, Michael Farrell, et al.
Pain Medicine (Malden, Mass.)|September 20, 2020
All-Cause and Overdose Mortality Risk Among People Prescribed Opioids: A Systematic Review and Meta-analysisSarah Larney, Amy Peacock, Lucy T Tran, et al.
Drug and Alcohol Dependence|March 10, 2018
Erratum to: A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release [Drug and Alcohol Dependence 184 (2018) 57-63]Lauren Brinkley-Rubinstein, Michelle McKenzie, Alexandria Macmadu, et al.
Drug and Alcohol Dependence|May 6, 2022
The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: Findings from the OATS retrospective linkage studyNicola R Jones, Matthew Hickman, Suzanne Nielsen, et al.
Drug and Alcohol Dependence|October 30, 2020
Risk of discharge against medical advice among hospital inpatients with a history of opioid agonist therapy in New South Wales, Australia: A cohort study and nested crossover-cohort analysisDan Lewer, Nicola R Jones, Matthew Hickman, et al.
The International Journal on Drug Policy|June 3, 2017
A mapping review of take-home naloxone for people released from correctional settingsMeredith Horton, Rebecca McDonald, Traci C Green, et al.
The International Journal on Drug Policy|August 10, 2017
Hepatitis C testing in general practice settings: A cross-sectional study of people who inject drugs in AustraliaKerryn Butler, Carolyn Day, Rachel Sutherland, et al.
Pageof 19